Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02170727 |
|---|---|
| Brief Title: | A Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1 (UNITY 4) |
| First Submitted : | June 20, 2014 |
| First Submitted that Met QC Criteria : | June 20, 2014 |
| First Posted : | June 23, 2014 (Estimate) |
| Results First Submitted : | March 22, 2019 |
| Results First Submitted that Met QC Criteria : | July 9, 2019 |
| Results First Posted : | August 16, 2019 |
| Certification/Extension First Submitted : | March 22, 2017 |
| Certification/Extension First Submitted that Met QC Criteria : | March 22, 2017 |
| Certification/Extension First Posted : | March 23, 2017 |
| Last Update Submitted that Met QC Criteria : | October 27, 2020 |
| Last Update Posted : | October 29, 2020 |